Gout Medications: Complete Guide to Pain Relief & Prevention

Medically reviewed | Last reviewed: | Evidence level: 1A
Gout is a painful form of inflammatory arthritis caused by uric acid crystal deposits in the joints. Treatment involves two main approaches: medications for acute attacks (NSAIDs, colchicine, corticosteroids) to relieve pain and inflammation, and long-term medications (allopurinol, febuxostat, probenecid) to lower uric acid levels and prevent future attacks. This guide explains how each medication works, when to use them, and important considerations for safe and effective treatment.
📅 Updated:
Reading time: 12 minutes
Written and reviewed by iMedic Medical Editorial Team | Specialists in rheumatology and internal medicine

📊 Quick facts about gout medications

Attack Duration
1-3 weeks
without treatment
NSAID Relief
24-48 hours
for pain reduction
Target Uric Acid
<6 mg/dL
for prevention
Flare Reduction
Up to 80%
with urate-lowering therapy
Prevention Duration
Lifelong
for most patients
ICD-10 Code
M10
Gout

💡 Key takeaways about gout treatment

  • Two treatment phases: Acute attack medications (NSAIDs, colchicine, corticosteroids) for immediate relief, and urate-lowering therapy (allopurinol, febuxostat) for long-term prevention
  • Start treatment early: Medications work best when started within 24 hours of gout attack onset
  • Never start allopurinol during an attack: Begin urate-lowering therapy only after the attack has completely resolved
  • Continue preventive medication during flares: If already taking allopurinol or febuxostat, do not stop during an acute attack
  • Target uric acid below 6 mg/dL: This prevents crystal formation and future attacks
  • Prevention is usually lifelong: Most patients need to continue urate-lowering therapy indefinitely to prevent recurrence

What Is Gout and Why Does It Need Treatment?

Gout is a type of inflammatory arthritis caused by the buildup of uric acid crystals in joints, most commonly affecting the big toe. It causes sudden, severe attacks of pain, swelling, and redness that can last 1-3 weeks. Without proper treatment, attacks become more frequent and can lead to permanent joint damage, tophi (urate crystal deposits), and kidney stones.

Gout develops when uric acid levels in the blood become too high, a condition called hyperuricemia. Uric acid is a natural waste product created when the body breaks down purines, substances found in certain foods and produced by the body. Normally, uric acid dissolves in the blood, passes through the kidneys, and leaves the body in urine. However, when the body produces too much uric acid or the kidneys cannot excrete enough, it accumulates and forms sharp, needle-like crystals in and around joints.

The crystals trigger an intense inflammatory response, causing the characteristic symptoms of a gout attack: sudden onset of severe joint pain (often described as the worst pain imaginable), dramatic swelling, redness, warmth, and extreme tenderness. The affected joint may be so sensitive that even the weight of a bedsheet becomes unbearable. Attacks typically begin at night and peak within 12-24 hours.

Without treatment, gout attacks typically last 7-14 days before gradually subsiding. However, the underlying problem remains, and without intervention to lower uric acid levels, attacks tend to become more frequent, more severe, and affect multiple joints. Over time, chronic gout can develop, characterized by persistent inflammation, permanent joint damage, and the formation of tophi - visible nodules of urate crystals that can erode bone and damage soft tissues.

Risk Factors for Gout

Several factors increase the likelihood of developing gout, including genetics, diet high in purines (red meat, organ meats, certain seafood), excessive alcohol consumption (especially beer), obesity, certain medications (diuretics, low-dose aspirin), and medical conditions such as kidney disease, hypertension, and metabolic syndrome. Understanding these risk factors is important because addressing modifiable factors through lifestyle changes can complement medication therapy.

How Are Acute Gout Attacks Treated?

Acute gout attacks are treated with anti-inflammatory medications: NSAIDs (like naproxen or indomethacin), colchicine, or corticosteroids. Treatment should begin as early as possible, ideally within 24 hours of symptom onset. The choice of medication depends on the patient's other health conditions, medications, and individual response. All three options are equally effective when used appropriately.

The primary goal of acute gout treatment is to rapidly reduce inflammation and relieve pain. Unlike prevention medications, these drugs do not lower uric acid levels - they address the inflammatory response to crystals already present in the joint. The sooner treatment begins, the faster symptoms resolve and the shorter the attack duration.

When choosing an acute treatment, healthcare providers consider several factors: the patient's kidney and liver function, cardiovascular health, history of gastrointestinal problems, other medications being taken, and previous response to gout treatments. Some patients may benefit from combination therapy, using two different medication classes together for severe attacks.

Regardless of which medication is chosen, patients should also rest the affected joint, apply ice packs (wrapped in a towel) for 20-minute intervals, stay well-hydrated, and avoid alcohol and purine-rich foods during the attack. These supportive measures complement medication therapy and may speed recovery.

NSAIDs for Gout Attacks

Nonsteroidal anti-inflammatory drugs (NSAIDs) are often the first-line treatment for acute gout attacks because they work quickly, are widely available, and are generally well-tolerated for short-term use. They work by blocking cyclooxygenase (COX) enzymes, which reduces the production of prostaglandins - inflammatory chemicals that cause pain, swelling, and fever.

For gout attacks, NSAIDs are used at maximum doses for a short period, typically until symptoms resolve plus an additional 2-3 days. Pain relief usually begins within 24-48 hours, though full resolution of inflammation may take 1-3 weeks. Common NSAIDs used for gout include naproxen, indomethacin, ibuprofen, and the COX-2 selective inhibitor etoricoxib.

Common NSAIDs used for acute gout attacks
Medication Typical Dosing Key Considerations
Naproxen 750mg initially, then 250mg every 8 hours Long-acting, good option for moderate attacks
Indomethacin 50mg three times daily Potent but more GI side effects
Ibuprofen 800mg three times daily Widely available, short-acting
Etoricoxib 120mg once daily COX-2 selective, less GI risk but cardiovascular concerns
Important NSAID precautions:

NSAIDs should be used with caution or avoided in patients with kidney disease, heart failure, history of gastrointestinal bleeding or ulcers, or those taking blood thinners. Older adults are at higher risk for NSAID side effects. If you have asthma, be aware that NSAIDs can trigger attacks in some people. Always take NSAIDs with food to reduce stomach irritation.

Colchicine for Gout

Colchicine is an ancient medication derived from the autumn crocus plant that has been used to treat gout for centuries. It works differently from NSAIDs - rather than blocking prostaglandin production, colchicine interferes with the ability of white blood cells to respond to urate crystals, effectively dampening the inflammatory cascade.

For acute attacks, colchicine is most effective when started within 12-24 hours of symptom onset. The modern low-dose regimen (1.2mg initially, followed by 0.6mg one hour later) is as effective as high-dose regimens but causes significantly fewer gastrointestinal side effects. Some patients may continue with 0.6mg once or twice daily until the attack resolves.

The most common side effects of colchicine are gastrointestinal: diarrhea, nausea, vomiting, and abdominal cramping. These side effects were more frequent with older high-dose regimens but still occur with current dosing. Colchicine has a narrow therapeutic window, meaning the difference between an effective dose and a toxic dose is relatively small, so it's important to follow dosing instructions carefully and not exceed recommended amounts.

Colchicine interactions:

Colchicine is metabolized by specific liver enzymes (CYP3A4) and transported by P-glycoprotein. Medications that inhibit these pathways, including clarithromycin, erythromycin, ketoconazole, cyclosporine, and some HIV medications, can dramatically increase colchicine levels and cause toxicity. Grapefruit juice can also interact with colchicine. Always inform your healthcare provider of all medications you take.

Corticosteroids for Gout

Corticosteroids are powerful anti-inflammatory medications that can be used when NSAIDs and colchicine are contraindicated or ineffective. They work by broadly suppressing the immune system's inflammatory response. Corticosteroids can be given orally (prednisone or prednisolone), by injection into the affected joint (intra-articular), or by intramuscular injection.

Intra-articular corticosteroid injection is particularly effective for gout affecting a single large joint. The medication is delivered directly to the site of inflammation, providing rapid relief (often within hours) while minimizing systemic side effects. This is an excellent option for patients who cannot take oral medications.

Oral corticosteroids, typically prednisone 30-40mg daily tapered over 7-10 days, are as effective as NSAIDs for acute gout. However, they can cause temporary increases in blood sugar (important for diabetic patients), fluid retention, mood changes, and difficulty sleeping. Short courses are generally well-tolerated, but long-term corticosteroid use has significant side effects including osteoporosis, weight gain, and increased infection risk.

What Medications Prevent Gout Attacks?

Urate-lowering therapy (ULT) with medications like allopurinol, febuxostat, or probenecid prevents gout attacks by reducing blood uric acid levels below the point where crystals can form (typically below 6 mg/dL). These medications don't treat acute attacks but rather prevent future ones. ULT is recommended for patients with frequent attacks, tophi, kidney stones, or very high uric acid levels and is usually continued lifelong.

While acute gout medications address the symptoms of an attack, they don't solve the underlying problem of elevated uric acid. Prevention medications work by either reducing uric acid production (xanthine oxidase inhibitors like allopurinol and febuxostat) or increasing uric acid excretion (uricosurics like probenecid). The goal is to maintain serum uric acid below 6 mg/dL (or below 5 mg/dL for patients with tophi), which gradually dissolves existing crystals and prevents new ones from forming.

The decision to start ULT depends on several factors: frequency of gout attacks (generally recommended for those with 2 or more attacks per year), presence of tophi, kidney stones, chronic kidney disease, or very high uric acid levels. Some guidelines also recommend considering ULT after the first attack in patients with significant risk factors.

An important principle of ULT is the "start low, go slow" approach. Beginning with a low dose and gradually increasing reduces the risk of triggering gout flares during treatment initiation. Paradoxically, lowering uric acid levels can initially provoke attacks as crystals dissolve and shift within joints. For this reason, prophylactic anti-inflammatory therapy (usually low-dose colchicine or an NSAID) is recommended during the first 3-6 months of ULT.

Allopurinol

Allopurinol is the most widely used urate-lowering medication and is effective, inexpensive, and well-studied. It works by inhibiting xanthine oxidase, the enzyme that converts hypoxanthine to xanthine and then to uric acid. By blocking this pathway, allopurinol reduces the body's production of uric acid.

Treatment typically begins at 100mg daily (50mg in patients with kidney disease) and is increased by 100mg every 2-4 weeks until target uric acid levels are achieved. Some patients require 300mg daily, while others may need 600-800mg for optimal control. Regular blood tests monitor uric acid levels and guide dose adjustments.

Allopurinol is generally well-tolerated, but side effects can include skin rash, gastrointestinal upset, and elevated liver enzymes. Rarely, a severe hypersensitivity syndrome can occur, characterized by severe skin reactions (including Stevens-Johnson syndrome), fever, and organ involvement. This serious reaction is more common in patients with certain genetic markers (HLA-B*5801) prevalent in Asian populations. Genetic testing before starting allopurinol may be recommended in high-risk groups.

Never start allopurinol during an acute attack:

Starting allopurinol during a gout flare can worsen and prolong symptoms. Wait until the attack has completely resolved before beginning therapy. However, if you are already taking allopurinol regularly when an attack occurs, continue taking it - stopping can cause uric acid fluctuations that trigger more attacks.

Febuxostat

Febuxostat is a newer xanthine oxidase inhibitor that offers an alternative for patients who cannot tolerate allopurinol or don't achieve target uric acid levels with it. Unlike allopurinol, febuxostat is metabolized primarily by the liver rather than the kidneys, making it potentially better suited for patients with mild to moderate kidney disease.

Standard dosing is 40-80mg once daily, with some patients requiring up to 120mg. Febuxostat is more potent at lowering uric acid than allopurinol at comparable doses, though this doesn't necessarily translate to better clinical outcomes.

Side effects are similar to allopurinol and include liver function abnormalities, nausea, and joint pain. An important consideration is cardiovascular safety: a large clinical trial (CARES) found higher cardiovascular mortality with febuxostat compared to allopurinol in patients with pre-existing cardiovascular disease. While later studies have been less conclusive, febuxostat is typically reserved as a second-line option after allopurinol in patients with cardiovascular disease.

Probenecid

Probenecid works differently from xanthine oxidase inhibitors - instead of reducing uric acid production, it increases excretion by blocking uric acid reabsorption in the kidneys. This makes it a uricosuric agent. It's primarily used when xanthine oxidase inhibitors are not tolerated or as an add-on therapy when XOI alone doesn't achieve target uric acid levels.

Because probenecid increases uric acid excretion through the kidneys, it's not suitable for patients with kidney stones or significant kidney disease. Patients starting probenecid need to drink plenty of fluids (at least 2 liters daily) to prevent stone formation from the increased uric acid load in urine. Some patients also take sodium bicarbonate to alkalinize urine and improve uric acid solubility.

Probenecid interacts with many medications, including penicillins, cephalosporins, and NSAIDs. It can enhance the effects of some drugs by reducing their kidney excretion. Therefore, medication review is essential before starting probenecid.

What Are the Side Effects of Gout Medications?

Common side effects vary by medication class: NSAIDs can cause stomach upset, ulcers, and kidney problems; colchicine commonly causes diarrhea and nausea; corticosteroids may increase blood sugar and cause mood changes; and urate-lowering drugs like allopurinol can cause skin rash. Serious side effects are uncommon but include severe allergic reactions (allopurinol), gastrointestinal bleeding (NSAIDs), and cardiovascular concerns (febuxostat in high-risk patients).

Understanding potential side effects helps patients and healthcare providers make informed treatment decisions and recognize problems early. Most side effects are mild and manageable, but some require prompt medical attention. The key is balancing the benefits of treatment (preventing painful attacks and joint damage) against potential risks.

Regular monitoring is an important part of gout medication management. This includes periodic blood tests to check kidney and liver function, uric acid levels, and complete blood counts. Patients should report new symptoms to their healthcare provider promptly, particularly skin rashes (which can signal hypersensitivity), signs of gastrointestinal bleeding (dark stools, vomiting blood), or symptoms of infection.

Side effects of common gout medications
Medication Common Side Effects Serious Side Effects (Rare)
NSAIDs Stomach upset, heartburn, nausea GI bleeding, ulcers, kidney injury, cardiovascular events
Colchicine Diarrhea, nausea, abdominal pain Bone marrow suppression, muscle damage, overdose toxicity
Corticosteroids Increased appetite, mood changes, insomnia High blood sugar, infections, osteoporosis (with long-term use)
Allopurinol Skin rash, GI upset Severe hypersensitivity syndrome (DRESS), Stevens-Johnson syndrome
Febuxostat Liver enzyme elevation, nausea, joint pain Possible increased cardiovascular mortality in high-risk patients
Probenecid GI upset, headache Kidney stones, blood cell abnormalities

When Should You Seek Medical Care?

Seek medical attention for your first gout attack (to confirm diagnosis), if symptoms don't improve after 48 hours of treatment, if fever develops (may indicate infection), if you cannot tolerate oral medications due to vomiting, or if you have multiple affected joints. Emergency care is needed for signs of severe infection or if you experience serious medication reactions like widespread skin rash or difficulty breathing.

While most gout attacks can be managed at home with prescribed medications, certain situations require professional evaluation. A first-ever attack should be evaluated by a healthcare provider to confirm the diagnosis, as other conditions can mimic gout (including septic arthritis, which is a medical emergency). Diagnosis typically involves joint fluid analysis to identify urate crystals and blood tests.

If you're already diagnosed with gout and an attack doesn't improve with your usual treatment after 48 hours, contact your healthcare provider. The attack may be particularly severe, a different joint condition may be present, or your treatment regimen may need adjustment. Similarly, if you develop fever during an attack, seek evaluation promptly - while mild fever can occur with gout, high fever suggests possible joint infection, which requires immediate treatment.

Patients experiencing signs of medication side effects should also seek medical attention. Warning signs include severe or widespread skin rash (especially with fever), black or bloody stools, severe abdominal pain, difficulty breathing, or unusual bleeding or bruising. These may indicate serious reactions requiring prompt evaluation and treatment modification.

How Do Lifestyle Changes Support Gout Treatment?

Lifestyle modifications can significantly complement medication therapy for gout. Key changes include limiting purine-rich foods (red meat, organ meats, certain seafood), avoiding alcohol (especially beer), staying well-hydrated, maintaining a healthy weight, and avoiding fructose-sweetened beverages. While lifestyle changes alone rarely cure gout, they can reduce attack frequency and may allow lower medication doses.

Diet plays an important role in gout management. High-purine foods that should be limited include organ meats (liver, kidney), red meat, certain seafood (anchovies, sardines, mussels, scallops), and meat-based gravies and broths. Alcohol, particularly beer, is strongly associated with gout attacks and should be avoided or consumed sparingly. Fructose-sweetened soft drinks have also been linked to higher uric acid levels and gout risk.

Foods that may help include low-fat dairy products, which have been associated with lower uric acid levels and reduced gout risk. Cherries and cherry juice have shown some benefit in reducing gout flares in clinical studies, possibly due to their anti-inflammatory properties. Coffee consumption (both regular and decaffeinated) is associated with lower uric acid levels and reduced gout risk, though it's not a treatment per se.

Weight management is important because obesity is a significant risk factor for gout and can make it harder to achieve target uric acid levels. Gradual, sustainable weight loss through healthy eating and regular physical activity can improve gout outcomes. However, rapid weight loss or fasting should be avoided as they can trigger gout attacks.

Staying well-hydrated (at least 2-3 liters of fluids daily, primarily water) helps the kidneys excrete uric acid and may reduce attack risk. This is particularly important for patients taking uricosuric medications like probenecid. Avoiding dehydration during hot weather or exercise is also important for gout management.

Medication review:

Some medications can raise uric acid levels and trigger gout attacks. These include thiazide and loop diuretics, low-dose aspirin, cyclosporine, and some chemotherapy drugs. If you're taking any of these medications, don't stop them without consulting your healthcare provider - the benefits may outweigh the gout risk, and alternative treatments or additional gout prevention may be needed.

Frequently asked questions about gout medications

Medical References and Sources

This article is based on current medical research and international guidelines. All claims are supported by scientific evidence from peer-reviewed sources.

  1. FitzGerald JD, et al. (2020). "2020 American College of Rheumatology Guideline for the Management of Gout." Arthritis Care & Research Comprehensive guidelines for gout diagnosis and management. Evidence level: 1A
  2. Richette P, et al. (2022). "2022 updated EULAR evidence-based recommendations for the management of gout." Annals of Rheumatic Diseases European recommendations for gout treatment based on systematic literature review.
  3. Dalbeth N, et al. (2021). "Gout." The Lancet 397(10287):1843-1855. Comprehensive seminar review on gout pathophysiology, diagnosis, and treatment.
  4. Hui M, et al. (2017). "The British Society for Rheumatology Guideline for the Management of Gout." British Society for Rheumatology guidelines with practical treatment algorithms.
  5. Cochrane Database of Systematic Reviews (2023). "Pharmacological management of gout." Cochrane Library Systematic reviews of gout treatment efficacy and safety.
  6. White WB, et al. (2018). "Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout." New England Journal of Medicine 378(13):1200-1210. CARES trial comparing cardiovascular outcomes of febuxostat vs allopurinol.

Evidence grading: This article uses the GRADE framework (Grading of Recommendations Assessment, Development and Evaluation) for evidence-based medicine. Evidence level 1A represents the highest quality of evidence, based on systematic reviews of randomized controlled trials.

iMedic Medical Editorial Team

Specialists in rheumatology, internal medicine, and pharmacology

Our Editorial Team

iMedic's medical content is produced by a team of licensed specialist physicians and medical experts with solid academic background and clinical experience. Our editorial team includes:

Rheumatology Specialists

Licensed physicians specializing in rheumatology and inflammatory joint diseases, with experience in gout management and crystal arthropathies.

Clinical Pharmacologists

Experts in medication therapy, drug interactions, and evidence-based pharmacological treatment of musculoskeletal conditions.

Clinicians

Practicing physicians with over 10 years of clinical experience treating patients with gout and related metabolic conditions.

Medical Review

Independent review panel that verifies all content against ACR, EULAR, and other international medical guidelines.

Qualifications and Credentials
  • Licensed specialist physicians with international specialist competence
  • Members of ACR (American College of Rheumatology) and EULAR
  • Documented research background with publications in peer-reviewed journals
  • Continuous education according to ACR, EULAR, and international guidelines
  • Follows the GRADE framework for evidence-based medicine

Transparency: Our team works according to strict editorial standards and follows international guidelines for medical information. All content undergoes multiple peer review before publication.

iMedic Editorial Standards

📋 Peer Review Process

All medical content is reviewed by at least two licensed specialist physicians before publication.

🔍 Fact-Checking

All medical claims are verified against peer-reviewed sources and international guidelines.

🔄 Update Frequency

Content is reviewed and updated at least every 12 months or when new research emerges.

✏ Corrections Policy

Any errors are corrected immediately with transparent changelog. Read more

Medical Editorial Board: iMedic has an independent medical editorial board consisting of specialist physicians in rheumatology, internal medicine, pharmacology, and general practice.